Multiple Sclerosis
Search for publications
Only original articles, editorials, guidelines.
-
Casanova B, Castillo J, Quintanilla-Bordás C, Sanz MT, Fernández-Velasco JI, Alcalá C, Carratalá S, Gasque R, Rubio A, Cubas L, Villar LM, Pérez-Miralles F.
Oligoclonal M bands unveil occult inflammation in multiple sclerosis.
MULTIPLE SCLEROSIS AND RELATED DISORDERS . 68: 104118-104118.
-
Costa-Frossard França L, Meca Lallana V, Labiano-Fontcuberta A, Blasco R, Monreal E, Martínez Ginés ML, Aguirre C, Sabin Muñoz J, Sainz de la Maza S, Cuello JP, Díaz-Pérez C, Chico García JL, Lozano Ros A, Rodríguez Jorge F, Martínez Martínez S, García Domínguez JM.
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.
Cns Drugs . : .
-
Calabrese M, Preziosa P, Scalfari A, Colato E, Marastoni D, Absinta M, Battaglini M, De Stefano N, Di Filippo M, Hametner S, Howell OW, Inglese M, Lassmann H, Martin R, Nicholas R, Reynolds R, Rocca MA, Tamanti A, Vercellino M, Villar LM, Filippi M, Magliozzi R.
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
ANNALS OF NEUROLOGY . : .